Neuronal Paraneoplastic Profile Serum

Paraneoplastic syndromes are rare conditions seen in cancer patients, caused not by tumor spread but by the body’s response to the cancer, either through substances released by tumor cells or an immune reaction that mistakenly attacks normal tissues. These syndromes can affect different organs, including the nerves, skin, blood, or the hormone system. In some cases, they may even appear before the cancer is diagnosed, giving doctors an early clue about the illness.

The Neuronal Paraneoplastic Profile Serum checks for antibodies that attack certain nerve proteins, such as amphiphysin, Ri, Yo, Titin (MGT30), HuD, CV2 (CRMP5), Ma1, Ma2, SOX1, Tr (DNER), Zic4, GAD65, PKCγ, and recoverin. If these antibodies are found, it can help doctors support the diagnosis of paraneoplastic syndromes and guide evaluation for underlying cancers like lung, breast, or ovarian cancer.

Doctors may recommend the Neuronal Paraneoplastic Profile Serum for individuals with unexplained neurological symptoms, those suspected of having paraneoplastic neurological syndromes, or patients with known cancers who develop neurological complications. The presence of these antibodies can support early identification of underlying cancers (often before the tumor is clinically evident) or useful in cases of unexplained neurological symptoms such as ataxia, neuropathy, seizures, or muscle weakness. It may also guide further investigations toward specific cancer types (e.g., lung, breast, ovarian, thymoma) which may be occult or hidden. It is also useful in cases of suspected autoimmune encephalitis or when the cause of neurological symptoms remains unclear. Symptoms that may require this test include muscle weakness, seizures, memory loss, confusion, personality or behavioral changes such as anxiety or hallucinations, vision problems, difficulty with coordination or walking, and numbness or tingling sensations.

No special preparation is needed for this test. However, a brief clinical history is required for this test. It is also important to inform the doctor about ongoing medications, or pregnancy, as these factors may influence interpretation.

Test result ranges can vary slightly between laboratories, depending on their methods and standards. The report should not be interpreted without medical guidance. It is advisable to consult the doctor, who will explain the results in the context of the individual’s symptoms and other investigations.